Log In
Print
BCIQ
Print
Print this Print this
 

DCVAC/OvCa

  Manage Alerts
Collapse Summary General Information
Company Sotio a.s.
DescriptionActive cellular immunotherapy for ovarian cancer that uses a patient's dendritic cells to induce an immune reaction against presented tumor antigens
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II
Standard IndicationOvarian cancer
Indication DetailsTreat epithelial ovarian cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today